US Bancorp, Cullen/Frost upped, Huntington Bank cut at Jefferies

BMS granted FDA review for label expansion of Merck-partnered anemia therapy

Glaukos hits new all-time high on Q2 results, raised 2026 revenue guidance

SiriusXM outlines 2026 targets of $8.525B revenue and $1.375B free cash flow while raising guidance by $25M

Mastercard expects Q3 2026 net revenue growth at the high end of the low double-digit range as BVNK deal closing nears